mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.006 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.009 |